1) Ishikawa T, Abe S, Kojima Y, et al:Prediction of a sustained viral response in chronic hepatitis C patients who undergo induction therapy with double filtration plasmapheresis plus interferon-β/ribavirin. Exp Ther Med 2015;9:1646-50 2) Morisue A, Fukuoka K, Goto R, et al:Hepatitis C virus-related glomerulonephritis with acute kidney injury requiring hemodialysis that improved with virus removal and eradication using double-filtration plasmapheresis without interferon. CEN Case Rep 2015;4:38-42 3) Zeniya M, Nakano M, Saeki C, et al:Usefulness of combined application of double-filtration plasmapheresis and twice-daily injections of interferon-β in hemodialysis patients with hepatitis C virus genotype 1b infection and a high viral load. Hepatol Res 2014;44:E257-60;doi:10.1111/hepr.12207 4) Cao H, Wen P, Ye H, et al:A study of the immunoloregulation of double filtration plasmapheresis in maintenance hemodialysis patients with chronic hepatitis C. PLoS One 2013;8:e82524;doi:10.1371/journal.pone.0082524 5) Ohara T, Oteki T, Suzuki T, et al:Efficacy of double filtration plasmapheresis with pegylated interferon/ribavirin therapy for intractable chronic hepatitis C patients and hepatitis C patients with combined liver cirrhosis by HBV, leading to early viral elimination. Hepatogastroenterology 2011;58:133-6 6) Ishikawa T, Higuchi K, Kubota T, et al:Complete early virological response was highly achieved by double filtration plasmapheresis plus IFN-beta induction therapy for HCV-1b patients with relapse or no response after previous IFN therapy. Ther Apher Dial 2011;15:400-5 7) Kim SR, Saito J, Imoto S, et al:Double-filtration plasmapheresis plus Interferon-β for HCV-1b patients with non-sustained virological response to previous combination therapy. Digestion 2011;84(Suppl 1):10-6 8) Kim SR, Imoto S, Kudo M, et al:Double-filtration plasmapheresis plus IFN for HCV-1b patients with non-sustained virological response to previous combination therapy:early viral dynamics. Intervirology 2010;53:44-8 9) Fujiwara K, Kaneko S, Kakumu S, et al, The Virus Reduction Therapy Study Group:Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load. Hepatol Res 2007;37:701-10 10) Yamashita T, Arai K, Sakai A, et al:Virological effects and safety of combined double filtration plasmapheresis(DFPP)and interferon therapy in patients with chronic hepatitis C:A preliminary study. Hepatol Res 2006;36:167-75